Fund VI will focus on investments in industrials and healthcare businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers
Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer
This biopharmaceutical facility is one most significant private sector investment ever in the Middletown region
Phase 1 dose-escalation study to be conducted at clinical sites in the U.S., the UK, Australia, and the Philippines
The card-to-cloud device was launched into the U.S. and many other markets and is designed to work without an embedded communications module.
The estimated capex is to the tune of Rs. 140 crore to be funded through debt and internal accrual
Donor privilege cards given to the families of all the donors from across Karnataka as a token of appreciation
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
Ivermectin Cream is a used for the treatment of inflammatory lesions of rosacea.
Subscribe To Our Newsletter & Stay Updated
